wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26798352-025D35C0-98A8-4567-BD78-4EAA6485616F
Q26798352-025D35C0-98A8-4567-BD78-4EAA6485616F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798352-025D35C0-98A8-4567-BD78-4EAA6485616F
PARP inhibitors in the management of breast cancer: current data and future prospects
P2860
Q26798352-025D35C0-98A8-4567-BD78-4EAA6485616F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798352-025D35C0-98A8-4567-BD78-4EAA6485616F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
90f10d086fa45298f4499dcae206d7667688f05c
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105